CClinicalTrials.gg
Status unknownNCT05178758Updated May 4, 2022

Effects of Virtual Reality Training for Stroke Patients

An interventional study of Virtual Reality (VR) in Stroke Patients, sponsored by Sultan Qaboos University. Status unknown. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2022-05-04.

Sponsored by Sultan Qaboos University · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

To examine the effects of using a virtual reality (VR) system to improve upper limb motor function among subacute hemiparetic stroke patients. Under this aim, the investigators have two objectives: (1) to develop and test a procedure for the quantitative assessment of stroke patients in a virtual environment; and (2) to compare the outcome measures of the two groups of stroke patients (VR-intervention vs. conventional-control) on these two modes of training.

Read the detailed description

After being informed about the study and potential risks, all participants who gave written consent will undergo the study. A randomized controlled trial with pre-/post-study, of 42 stroke patients with upper limb weakness (21 patients in the control group and 21 patients in the intervention group), 18-65 years old, all are newly admitted stroke patients in the rehabilitation clinic from one hospital. Participants in the intervention group will receive 60 minutes of VR training to improve upper limb function and daily living activities. Participants in the control group will receive 60 minutes of conventional training to improve upper limb function and daily living activities. The training includes grasp, grip, pinch, gross, and finger-hand coordination movement. The training will perform 5 times/week for 4 weeks. Two outcome measures: (a) The Barthel Index and (b) The Fugl-Meyer Assessment, time spent to complete a task were used to compare two groups.

02

Conditions studied

  • Stroke Patients

Browse trials for

Keywords

  • Hemiparetic stroke patients
  • Virtual reality
  • Impairment upper limbs
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 42 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Sultan Qaboos University is the lead sponsor of 49 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. New in-patients clinically diagnosed hemiparetic stroke patients;
  2. Patients with a history of the first incidence of stroke with upper limb weakness with a motor impairment upper limbs as a primary deficit;
  3. muscle strength > 2/5 on the Medical Research Council (MRC) scale;
  4. good cognitive ability as indicated by a score > 15 on the Mini-Mental State Examination (MMSE); Motricity Index sore > 26; and
  5. ability to communicate and sign the consent.

Exclusion criteria

Exclusion Criteria:

  1. In-patient with ataxia or any other cerebellar symptoms;
  2. orthopedic alterations or pain syndrome of the upper limb;
  3. peripheral nerve damage affecting the upper extremities;
  4. visual or hearing impairment (does not allow the possibility of interaction with the VR system);
  5. severe hemispatial neglect;
  6. severe shoulder or hand pain (unable to volitionally position the hand in the workspace without pain);
  7. insensate forearm and /or hand, edema of the affected forearm and /or hand;
  8. uncontrolled seizures disorder;
  9. severe depression (>13 on beck Depression inventory fast screen); and
  10. severely impaired cognition or comprehension.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Virtual Reality (VR) Rehabilitation Training

    Patients in the VR group will receive VR rehabilitation training in the hospital. The content of the training is the same as the control group. The only difference is that participants in the intervention group will use VR as a training platform. The VR system will include the training materials and tasks required for the patients to perform in the 3D environment. Demographic, clinical data and treatment costs will be collected before and after the rehabilitation training.

    Device: Virtual Reality (VR)

  • No intervention
    Control - Conventional Rehabilitation Training

    Patients in the control group will receive conventional rehabilitation training currently provided in the hospital. An instructor will assign each participant for training. Demographic, clinical data, and treatment costs will be collected before and after completing the rehabilitation training

Interventions

  • DeviceVirtual Reality (VR)

    Patients in the intervention (VR) group will receive a series of occupational and physical therapy rehabilitation training using the VR system. All training is consists of daily activities oriented by an occupational therapist, including grasp, grip, pinch, gross, and finger-hand coordination movement. Each training will take around 1 hour for one session per day 5 times per week over a maximum of 4 weeks. The training presented a one-on-one that allowed interaction between instructor (or VR system) and participant.

06

What researchers measure

Primary outcomes

  1. The Barthel Index (BI)

    To evaluate upper extremity performance motor function of the stroke patients. It consists of 10 self-care activities, including feeding, Bathing, Bowels, Bladder, Toilet Use, Transfer (bed to chair, and back), Mobility (on level surfaces), stairs, etc. with a total score range from 0 to 100, the higher the score, the more independent on their daily activities; It has good validity (0.82) and reliability (0.83).

    Time frame: Change from baseline scores on the Barthel index after 4 weeks training

  2. The Fugl-Meyer Assessment (FMA)

    To evaluate the upper limb movements, including the functions on the shoulder, elbow, forearm, wrist, and hand functions of the hemiparetic arm. The FMA is measured on 33 tasks with a 3-point ordinal scale (0 to 2), with a total score range from 0 to 66; the higher the score, the more functioning of the upper limb. It has good validity (0.84) and reliability (0.79).

    Time frame: Change from baseline scores on the Fugl-Meyer Assessment after 4 weeks training

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 4, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05178758
Lead sponsor
Sultan Qaboos University
Responsible party
Moon Fai Chan, PhD (Associate Professor, Sultan Qaboos University) — Principal investigator
First posted
Jan 5, 2022
Start date
Jun 1, 2022 (estimated)
Primary completion
Aug 31, 2023 (estimated)
Completion
Sep 30, 2023 (estimated)
Last update
May 4, 2022

Study contacts

Moon Fai Chan
Contact
moonf@squ.edu.om
+968 24141132
Hamdan Al Habsi
Contact
habsi@squ.edu.om
+968 24141128
Moon Fai Chan
principal investigator · Sultan Qaboos University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion